Focus on the use of Green Tea in cancer setting: between lights and shadows

Focus on the use of Green Tea in cancer setting: between lights and shadows WCRJ 2023; 10: e2581
DOI: 10.32113/wcrj_20236_2581

Topic: Complementary and alternative medicine Category: Opinion paper

Berretta M. Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
berrettama@gmail.com , Di Francia R. IAPharmagen, Italian Association of Pharmacogenomics and Molecular Diagnostics, Ancona, Italy Abstract

Green tea (GT) is a beverage derived from the unfermented leaves of Camellia sinensis, a plant native to Asia. Green tea extract is marketed as an antioxidant and dietary supplement to support cardiovascular, metabolic, cognitive, and cellular health. Data on the use of GT in oncology are controversial, mainly because of the risk of interference with anticancer drugs. To date, the use of GT is recommended as supportive treatment in most oncological diseases.

To cite this article Berretta M. Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
berrettama@gmail.com , Di Francia R. IAPharmagen, Italian Association of Pharmacogenomics and Molecular Diagnostics, Ancona, Italy Focus on the use of Green Tea in cancer setting: between lights and shadows

WCRJ 2023; 10: e2581
DOI: 10.32113/wcrj_20236_2581

Publication History

Submission date: 19 May 2023

Revised on: 08 Jun 2023

Accepted on: 19 Jun 2023

Published online: 20 Jun 2023